Concomitant diseases in primary joint hypermobility syndrome;Begleiterkrankungen bei primärer gelenkhypermobilität

Medizinische Klinik

Volumn 99, Issue 10, 2004, Pages 585-590

  Skoumal, Martin ^a,b,d   Haberhauer, Günther ^a   Mayr, Hans ^c  

^a Institut fur Rheumatologie   (Austria)

^b Rheumasonderkrankenanstalt der SVA   (Austria)

^c Inst F Phys Med und Rehab   (Austria)

^d NONE   (Austria)

Author keywords

Aortic aneurysms; Aortic incompetence; Joint hypermobility; Mitral valve prolapse; Rupture of aneurysms

Indexed keywords

ANEURYSM RUPTURE; AORTA ANEURYSM; CONNECTIVE TISSUE DISEASE; DISEASE CLASSIFICATION; EHLERS DANLOS SYNDROME; HUMAN; JOINT HYPERMOBILITY; MARFAN SYNDROME; MITRAL VALVE PROLAPSE; OSTEOGENESIS IMPERFECTA; REVIEW; SYNDROME DELINEATION;

ADOLESCENT; ADULT; AGE FACTORS; AORTIC RUPTURE; AORTIC VALVE INSUFFICIENCY; BACK PAIN; CHILD; DIAGNOSIS, DIFFERENTIAL; DISLOCATIONS; EHLERS-DANLOS SYNDROME; FEMALE; HUMANS; JOINT INSTABILITY; MALE; MARFAN SYNDROME; MITRAL VALVE PROLAPSE; OSTEOGENESIS IMPERFECTA; RECURRENCE; SEX FACTORS; SYNDROME; TIME FACTORS;

EID: 6344260675     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00063-004-1086-6     Document Type: Review

References (73)

1. Acasuso Diaz M, Collantes-Estevez E. Joint hypermobility in patients with fibromyalgia syndrome. Arthritis Care Res 1998;11:39-42.
2. Adair SM, Hecht C. Association of generalized joint hyper mobility with history, signs, and symptoms of temporomandibular joint dysfunction in children. Pediatr Dent 1993;15:323-6.
3. Al-Rawi ZS, Al-Rawi ZT. Joint hypermobility in women with genital prolapse. Lancet 1982;24:1439-41.
4. Al-Rawi ZS, Nessan AH. Joint hypermobility in patients with chondromalacia patellae. Br J Rheumatol 1997;36:1324-7.
5. Avlonitis VS, Large SR. Ehlers-Danlos syndrome: surgical management of mitral regurgitation and atrial fibrillation. J Heart Valve Dis 1999;8:463-5.
6. Barabas AP. Ehlers-Danlos syndrome: associated with prematurity, premature rupture of foetal membranes: possible increase in incidence. Br Med J 1966;5515:682-4.
7. Bayles J. Sounding the alarm. If undetected, Marfan syndrome can be a silent killer. J Ark Med Soc 2002;99:106-11.
8. Beighton P, De Paepe A, Steinmann B, et al. Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Am J Med Genet 1998;77:31-7.
9. Beighton P, Grahame R, Bird H. Hypermobility of joints, 3rd edn. London: Springer, 1999.
10. Beighton P, Horan FT. Dominant inheritance of familial generalised articular hypermobility. J Bone Joint Surg 1970;52:145-7.
11. Binns M. Joint laxity in idiopathic adolescent scoliosis. J Bone Joint Surg Br 1988;70:420-2.
12. Bird HA, Tribe CR, Bacon PA. Joint hypermobility leading to osteoarthrosis and chondrocalcinosis. Ann Rheum Dis 1978:37:203-11.
13. Bird HA, Wright V. Joint hypermobility mimicking pauci-articular juvenile polyarthritis. Br Med J 1978;2:402-3.
14. Bridges AJ, Smith E, Reid J. Joint hypermobility in adults referred to rheumatology clinics. Ann Rheum Dis 1992;51:793-6.
15. Brown OR, Demots H, Kloster JE, et al. Aortic root dilatation and mitral valve prolapse in Marian's syndrome. Circulation 1975;52:651-7.
16. Bulbena A, Duro JC, Porta M, et al. Anxiety disorders in the joint hypermobility syndrome. Psychiatry Res 1993;46:59-68.
17. Burn J, Camm J, Davies MJ, et al. The phenotype/genotype relation and the current status of genetic screening in hypertrophic cardiomyopathy, Marfan syndrome, and the long QT syndrome. Heart 1997;78:110-6.
18. Child AH. Joint hypermobility syndrome: inherited disorder of collagen synthesis. J Rheumtol 1986;13:239-43.
19. Cotton DJ, Brandt KD. Cardiovascular abnormalities in the Marfanoid hypermobility syndrome. Arthritis Rheum 1976;19:763-8.
20. Davidovitch M, Tirosh E, Tal Y. The relationship between joint hypermobility and neurodevelopmental attributes in elementary school children. J Child Neurol 1994;9:417-9.
21. De Paepe A, Devereux RB, Dietz HC, et al. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 1996;62:417-26.
22. Devereux RB, Roman MJ. Aortic disease in Marian's syndrome. NEJM 1999;340:1358-9.
23. Dolan AL, Mishra MB, Chambers JB, et al. Clinical and echocardiographic survey of the Ehlers-Danlos syndrome. Br J Rheumatol 1997;36:459-62.
24. Elkayam U, Ostrzega E, Shotan A, et al. Cardiovascular problems in pregnant women with the Marfan syndrome. Ann Intern Med 1995;123:117-22.
25. Fitzcharles MA. Is hypermobility a factor in fibromyalgia? J Rheumatol 2000;27:1587-8.
26. Gedalia A, Person DA, Giannini EH, et al. Joint hypermobility in juvenile episodic arthritis/arthralgia. J Rheumatol 1984;11:716.
27. Gilchrist DM, Marfan syndrome or Marfan-like connective-tissue disorder. Am J Hum Genet 1994;54:553-4.
28. Gillinov AM, Huiyalkar A, Cameron DE, et al. Mitral valve operation in patients with the Marfan syndrome. J Thorac Cardiovasc Surg 1994;107:724-31.
29. Gott VL, Greene PS, Alejo DE, et al. Replacement of the aortic root in patients with Marfan's syndrome. NEJM 1999;340:1307-13.
30. Graham R. Hypermobility syndrome in the elderly. In: Rovensky J. ed. Proceedings of the 1st Central European Congress of Rheumtology. Piestany, Slovakia: Časlekčes, 1996.
31. Graham R, Bird HA, Child A, et al. The revised (Brighton 1998) criteria for the diagnosis of benign joint hypermobility syndrom (BJHS). J Rheumatol 2000;27:1777-9.
32. Grahame R. Joint hypermobility - clinical aspects. Proc R Soc Med 1971;64:692-4.
33. Greally MT, Carey JC, Milewicz DM, et al. Shprintzen-Goldberg syndrome: a clinical analysis. Am J Med Genet 1998;76:202-12.
34. Haberhauer G, Feyertag J, Hanusch-Enserer U. Joint hypermobility syndrome and bilateral occlusion of the ulnar arteries presenting as Raynaud's phenomenon. Clin Exp Rheumatol 2000;18:270-1.
35. Handler CE, Child A, Light ND, et al. Mitral valve prolapse, aortic compliance, and skin collagen in joint hypermobility syndrome. Br Heart J 1985;54:501-8.
36. Hayward C, Brock DJ. Fibrillin-1 mutations in Marfan syndrome and other type-1 fibrillinopathies. Hum Mutat 1997;10:415-23.
37. Hudson N, Fitzcharles MA, Cohen M, et al. The association of soft-tissue rheumatism and hypermobility. Br J Rheumatol 1998;37:382-6.
38. Jones CR, Van Itallie TB, Stevenson SS. Decrease in hydroxyproline excretion in a patient with Marfan's syndrome after methandrostenolone therapy. JAMA 1969;71:349-52.
39. Jonsson H, Valtysdottir ST, Kjartansson O, et al. Hypermobility associated with osteoarthritis of the thumb base: a clinical and radiological subset of hand osteoarthritis. Ann Rheum Dis 1996;55:540-3.
40. Karaaslan Y, Haznedaroglu S, Öztürk M. Joint hypermobility and primary fibromyalgia. A clinical enigma. J Rheumatol 2000;27:1774-6.
41. Kirk JH, Atisell BM, Bywaters EGL. The hypermobility syndrome. Ann Rheum Dis 1967;26:419-25.
42. Knudtzon J, Aarskog D. Estrogen treatment of excessively tall girls with Marfan syndrome. Acta Paediatr Scand 1988;77:537-41.
43. Labuda M, Morissette LM, Ward LM, et al. Osteogenesis imperfecta type VII maps to the short arm of chromosome 3. Bone 2002;31:19-25.
44. Lannoo E, De Paepe A, Leroy B, et al. Neuropsychological aspects of Marfan syndrome. Clin Genet 1996;49:65-9.
45. Larsson LG, Mudholkar GS, Baum J, et al. Benefits and liabilities of hypermobility in the back pain disorders of industrial workers. J Intern Med 1995;238:461-7.
46. Lewkonia RM, Ansell BM. Articular hypermobility simulating chronic rheumatic disease. Arch Dis Child 1983;58:988-92.
47. March LM, Francis H, Webb J. Benign joint hypermobility with neuropathies: documentation and mechanism of median, sciatic, and common peroneal nerve compression. Clin Rheumatol 1988;7:35-40.
48. Marshman D, Percy J, Fielding I, et al. Rectal prolapse: relationship with joint mobility. Aust N Z J Surg 1987;57:827-9.
49. Martin-Santos R, Bulbena A, Porta M, et al. Association between joint hypermobility syndrome and panic disorder. Am J Psychiatry 1998;155:1578-83.
50. McIntosh LJ, Stanitski D, Mallett VT, et al. Ehlers-Danlos syndrome: relationship between joint hypermobility, urinary incontinence, and pelvic floor prolaps. Gynecol Obstet Invest 1996;41:135-9.
51. Merza AP, Raiser MW. Biliary tract manifestations of the Marfan syndrome. Am J Gastroenterol 1987;82:779-82.
52. Mishra MB, Ryan P, Atkinson P, et al. Extra-articular features of benign joint hypermobility syndrome. Br J Rheumatol 1996;35:861-6.
53. Morales-Rosello J, Hernandez-Yago J, Pope M. Type III Ehlers-Danlos syndrome and pregnancy. Arch Gynecol Obstet 1997;26:39-43.
54. Morgan AW, Pearson SB, Bird HA, Respiratory symptoms in Ehlers-Danlos syndrome and the benign joint hypermobility syndrome. Arthritis Rheum 1996;39:S136.
55. Mukherjee SK. A case of the Marfan syndrome in an old lady of 72 with marked cardiovascular involvement. Br J Clin Pract 1970;24:334-8.
56. Pereira L, Levran O, Ramirez F, et al. A molecular approach to the stratification of cardiovascular risk in families with Marfan's syndrome. NEJM 1994;331:148-53.
57. Peters KF, Home R, Kong F, et al. Living with Marfan syndrome II. Medication adherence and physical activity modification. Clin Genet 2001;60:283-92.
58. Pineda C, Zenteno M, Fernandez-Tapia S, et al. Dural ektasia in the Marfan syndrome. Am Coll Rheum 1993;57:S117.abstract 116.
59. Pitcher D, Graham R. Mitral valve prolapse and joint hyper mobility: evidence for a systemic connective tissue abnormality? Ann Rheum Dis 1982;41:352-4.
60. Porciani MC, Giurlani L, Chelucci A, et al. Diastolic subclinical primary alterations in Marfan syndrome and Marfan-related disorders. Clin Cardiol 2002;25:416-20.
61. Russek LN. Examination and treatment of a patient with hypermobility syndrome. Phys Ther 2000;80:386-9.
62. Ryan-Krause P. Identify and manage Marfan syndrome in children. Nurse Pract 2002;27:31-6.
63. Sachdev NH, Di Girolamo N, McClusky P. Lens dislocation in Marfan syndrome: potential role of matrix metalloproteinases in fibrillin degradation. Arch Ophthalmol 2002;120:833-5.
64. Santos-Ocampo AS, Huffman GS. Aneurysms and hypermobility in a 45-year-old woman. Cleve Clin J Med 1999;66:426-33.
65. Sastry PS. Matrixmetalloproteinase inhibitor therapy to prevent complications as well as therapy for Ehlers-Danlos syndrome. Med Hypotheses 2002;59:314-5.
66. Scharty Y, Nahir AM. Hypermobility syndrome mimicking juvenile chronic arthritis. Rheumatol Rehabil 1982;21:78-80.
67. Schilling F, Stofft E. Das Hypermobilitätssyndrom, Übersicht, großfamiliäre Kasuistik und Pathologie der Kollagentextur. Osteologie 2003;12:205-32.
68. Shabat S. Osteogenesis imperfecta-induced migratory stress fractures in a military recruit. Clin Exp Rheumatol 2000;18:654.
69. Shashikirian U, Rastogi A, Gupta RP, et al. Ehlers-Danlos syndrome type VI variant presenting with recurrent respiratory infections and responding to high dose vitamin C. J Assoc Physicians India 1999;47:554-5.
70. Shores J, Berger KR, Murphy EA, et al. Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome. NEJM 1994;330:1335-41.
71. Van Ooijen B. Marfan's syndrome and isolated aneurysm of the abdominal aorta. Br Heart J 1988;59:81-4.
72. Ward LM, Rauch F, Travers R, et al. Osteogenesis imperfecta type VII: an autosomal recessive form of brittle bone disease. Bone 2002;31:12-8.
73. Woodward EG, Morris MT. Joint hypermobility in keratoconus. Ophthalmic Physiol Opt 1990;10:360-2.